Pulmonx Corp Files 8-K on Financial Condition
Ticker: LUNG · Form: 8-K · Filed: May 1, 2024 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | 8-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations-update
TL;DR
Pulmonx filed an 8-K updating investors on financial results.
AI Summary
Pulmonx Corporation filed an 8-K on May 1, 2024, to report on its Results of Operations and Financial Condition. The filing does not contain specific financial figures or operational details in the provided excerpt, but it serves as a notification of these updates.
Why It Matters
This filing indicates Pulmonx is providing updates on its financial performance and operational status to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard procedural update and does not contain negative news or significant changes.
Key Players & Entities
- Pulmonx Corporation (company) — Registrant
- May 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39562 (identifier) — SEC File Number
- 77-0424412 (identifier) — IRS Employer Identification No.
- 700 Chesapeake Drive Redwood City, CA 94063 (address) — Address of Principal Executive Offices
- 650-364-0400 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are being reported by Pulmonx Corporation in this 8-K filing?
The provided excerpt of the 8-K filing does not contain specific financial figures or detailed operational updates. It only indicates that the report pertains to 'Results of Operations and Financial Condition'.
When was the earliest event reported in this Form 8-K filing?
The earliest event reported in this Form 8-K filing was on May 1, 2024.
Under which section of the Securities Exchange Act of 1934 is Pulmonx Corporation filing this Current Report?
Pulmonx Corporation is filing this Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the principal executive office address for Pulmonx Corporation?
The address of Pulmonx Corporation's Principal Executive Offices is 700 Chesapeake Drive, Redwood City, CA 94063.
What is the SEC File Number for Pulmonx Corporation?
The SEC File Number for Pulmonx Corporation is 001-39562.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-05-01 16:10:26
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value LUNG The Nasdaq Stock Market
Filing Documents
- lung-20240501.htm (8-K) — 27KB
- lung1q24earningsrelease050.htm (EX-99.1) — 105KB
- pulmonxlogoa.jpg (GRAPHIC) — 8KB
- 0001127537-24-000045.txt ( ) — 274KB
- lung-20240501.xsd (EX-101.SCH) — 2KB
- lung-20240501_lab.xml (EX-101.LAB) — 21KB
- lung-20240501_pre.xml (EX-101.PRE) — 12KB
- lung-20240501_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On May 1, 2024, Pulmonx Corporation (the "Company") issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2024. A copy of the Company's press release dated May 1, 2024, titled "Pulmonx Reports First Quarter 2024 Financial Results" is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information (including the exhibit hereto) is being furnished under "Item 2.02 Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated May 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pulmonx Corporation Dated: May 1, 2024 By: /s/ Mehul Joshi Mehul Joshi Chief Financial Officer